Security key
753018100
Rani Therapeutics Holdings, Inc. - Common Stock (RANI)
CUSIP: 753018100
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 4,033,213
- Total 13F value
- $2,015,817
- Share change
- -2,425,419
- SEC-reported price per share
- $0.50
- Number of holders
- 36
- Value change
- -$1,258,453
- Number of buys
- 13
- Number of sells
- 13
- Shares outstanding
- 112,535,902
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
36
Top holders
10
RANI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Rani Therapeutics Holdings, Inc. SEC filings
Rani Therapeutics Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 753018100
Recent filing periods:
Ownership snapshot
Top reported holders of RANI - Rani Therapeutics Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 5%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
Orca Capital AG
4.3%
Nan Fung Group Holdings Ltd
0.44%
MYDA Advisors LLC
0.39%
UNITED SERVICES AUTOMOBILE ASSOCI...
0.27%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
|
$2,865,831
2,515,652 shares
|
-$2,046,803 | 30 Sep 2025 |
| Orca Capital AG |
13D/G
|
4.3%
|
$972,105
1,891,623 shares
|
-$1,265,416 | 22 Jul 2025 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
0.44%
|
$253,653
493,584 shares
|
— | 30 Jun 2025 |
| MYDA Advisors LLC |
13F
Company
|
0.39%
|
$165,485
57,862 shares
|
— | 30 Jun 2025 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
Company
|
0.27%
|
$155,580
302,743 shares
|
— | 30 Jun 2025 |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
Company
|
0.18%
|
$104,419
203,190 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
36
Shares
4,033,213
Rows available
36
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
38
Q3 2025 holders
36
Holder diff
-2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend